M. Sayago Mota

Response to vaccination against hepatitis B virus with a schedule of four 40-μg doses in cirrhotic patients evaluated for liver transplantation: factors associated with a response.

G. Suárez Artacho, Á. Giráldez Gallego, J. M. Sousa Martín, 2012, Transplantation proceedings.

Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantation.

M. G. Gómez Bravo, Á. Giráldez Gallego, R. García Jiménez, 2012, Transplantation proceedings.

Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.

G. Suárez Artacho, Á. Giráldez Gallego, J. M. Sousa Martín, 2012, Transplantation proceedings.